drugset / Trial / NCT02957864

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide

NCT02957864

RandomizedParallel-groupOpen-labelTreatment

Summary

Tenofovir disoproxil fumarate (TDF) is one of the most frequently used drugs to treat HIV. Long term use of TDF can induce renal toxicity. Tenofovir alafenamide (TAF) is a new pro-drug of Tenofovir which has not been associated with renal toxicity and may therefore be a good substitute for TDF in patients with TDF induced renal toxicity. Abacavir (ABC) is another drug that can be used for the treatment of HIV and is not associated with renal toxicity. In this study the investigators will compare the effect on renal function of a switch from TDF to TAF with a switch from TDF to ABC in patients with TDF induced renal insufficiency.

Timeline

Start
2016-10
Primary completion
2020-06
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Abacavir Other / unclassified
Subject tenofovir alafenamide Small molecule 25 mg